Serial Number | 79292101 |
Word Mark | ONCOCOLLAPSE |
Filing Date | Monday, June 29, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 11, 2021 |
Registration Number | 6344206 |
Registration Date | Tuesday, May 11, 2021 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 23, 2021 |
Goods and Services | Pharmaceutical drugs based on peptides for treating oncological diseases; peptides as drugs to induce protein aggregation for treating oncological diseases; peptides as drugs to induce protein aggregation resulting in proteostatic collapse for treating oncological diseases |
Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development of pharmaceutical products and drugs based on peptides; pharmaceutical research and development of pharmaceutical products and drugs based on protein aggregation stimulating peptides; pharmaceutical research and development of pharmaceutical products and drugs based on aggregation stimulating peptides leading to proteostatic collapse |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 21, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 21, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | AELIN THERAPEUTICS |
Party Type | 30 - Original Registrant |
Legal Entity Type | 32 - NOT AVAILABLE |
Address | BE |
Party Name | AELIN THERAPEUTICS |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 32 - NOT AVAILABLE |
Address | BE |
Party Name | AELIN THERAPEUTICS |
Party Type | 10 - Original Applicant |
Legal Entity Type | 32 - NOT AVAILABLE |
Address | BE |
Event Date | Event Description |
Friday, September 24, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Monday, September 20, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, August 26, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
Thursday, August 26, 2021 | FINAL DISPOSITION PROCESSED |
Wednesday, August 11, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, May 11, 2021 | REGISTERED-PRINCIPAL REGISTER |
Friday, April 2, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, February 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 23, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, February 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, January 18, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, January 15, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, January 15, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, January 15, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, November 14, 2020 | REFUSAL PROCESSED BY IB |
Saturday, October 24, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Saturday, October 24, 2020 | REFUSAL PROCESSED BY MPU |
Saturday, October 3, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Friday, October 2, 2020 | NON-FINAL ACTION WRITTEN |
Thursday, October 1, 2020 | ASSIGNED TO EXAMINER |
Tuesday, August 25, 2020 | APPLICATION FILING RECEIPT MAILED |
Friday, August 21, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, August 20, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |